推荐产品
product name
γ分泌酶抑制剂 XX, This γ-secretase inhibitor, CAS 209984-56-5, is a cell-permeable dibenzazepine compound that lowers both brain and plasma Aβ40 levels by ~72% in Tg2576 mutant APP transgenic mouse model.
品質等級
化驗
≥95% (HPLC)
形狀
solid
製造商/商標名
Calbiochem®
儲存條件
OK to freeze
protect from light
顏色
white
溶解度
DMSO: 10 mg/mL
運輸包裝
ambient
儲存溫度
−20°C
InChI
1S/C26H23F2N3O3/c1-15(29-23(32)13-16-11-17(27)14-18(28)12-16)25(33)30-24-21-9-4-3-7-19(21)20-8-5-6-10-22(20)31(2)26(24)34/h3-12,14-15,24H,13H2,1-2H3,(H,29,32)(H,30,33)/t15-,24-/m0/s1
InChI 密鑰
QSHGISMANBKLQL-OWJWWREXSA-N
一般說明
一种细胞渗透性二苯并氮杂(dbz)化合物,可作为有效的γ-分泌酶抑制剂,在Tg2576突变APP转基因小鼠模型(100 µmol/kg, b.i.d)中,显著降低脑和血浆Aβ40水平,约72%。诱导肠道中隐窝结构增殖单位和结肠干细胞生态位的异质重组。在C57BL/6和ApcMin小鼠模型(10 µmol/kg,i.p.)中,还可能抑制Notch加工(在SupT1细胞中IC50 = 1.7 nM),并诱导增殖隐窝细胞转化为有丝分裂后杯状细胞。
一种细胞渗透性有效γ-分泌酶抑制剂,在Tg2576突变APP转基因小鼠模型(100 µmol/kg,b.i.d.)中可显著降低脑和血浆Aβ40水平,约72%。诱导肠道中隐窝结构增殖单位和结肠干细胞生态位的异质重组。在C57BL/6和ApcMin小鼠模型(10 µmol/kg,i.p.)中,还可能抑制Notch加工(在SupT1细胞中IC50 = 1.7 nM),并诱导增殖隐窝细胞转化为有丝分裂后杯状细胞。
生化/生理作用
产物不与ATP竞争。
可逆:否
细胞可渗透性:是
靶标IC50:1.7 nM抑制SupT1细胞中的Notch加工
包裝
用惰性气体包装
警告
毒性:标准处理(A)
其他說明
Droy-Dupré, L., et al. 2012.Dis.Model Mech.5, 107.
van Es, J.H., et al. 2005.Nature435, 959.
Milano, J., et al. 2004.Toxicol.Sci.82, 341.
van Es, J.H., et al. 2005.Nature435, 959.
Milano, J., et al. 2004.Toxicol.Sci.82, 341.
法律資訊
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
訊號詞
Warning
危險聲明
危險分類
Acute Tox. 4 Oral - Skin Sens. 1A
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
WGK 3
閃點(°F)
Not applicable
閃點(°C)
Not applicable
其他客户在看
Cells, 11(9) (2022-05-15)
The top genetic association signal for type 2 diabetes (T2D) in Southwestern American Indians maps to intron 15 of KCNQ1, an imprinted gene. We aim to understand the biology whereby variation at this locus affects T2D specifically in this genomic
Current protocols in human genetics, 100(1), e71-e71 (2018-10-20)
The International Diabetic Federation estimated that 415 million adults currently have diabetes and 318 million adults had impaired glucose tolerance, putting them at high risk of developing diabetes in the future. In Type 1 Diabetes (T1D), the β cells are
Cell stem cell, 27(1), 137-146 (2020-05-23)
GATA6 is a critical regulator of pancreatic development, with heterozygous mutations in this transcription factor being the most common cause of pancreatic agenesis. To study the variability in disease phenotype among individuals harboring these mutations, a patient-induced pluripotent stem cell
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门